These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 9688312

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K, Yamagishi M, Son HY, Imazawa T, Furukawa F, Nakamura H, Nishikawa A, Masegi T, Hirose M.
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Reversibility of proliferative lesions and induction of non-papillary tumors in rat urinary bladder treated with phenylethyl isothiocyanate.
    Sugiura S, Ogawa K, Hirose M, Takeshita F, Asamoto M, Shirai T.
    Carcinogenesis; 2003 Mar; 24(3):547-53. PubMed ID: 12663517
    [Abstract] [Full Text] [Related]

  • 7. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL, Shirai T, Kato T, Asamoto M, Fukushima S.
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 9. Effects of urinary potassium and sodium ion concentrations and pH on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in rats.
    Lina BA, Woutersen RA.
    Carcinogenesis; 1989 Sep; 10(9):1733-6. PubMed ID: 2548752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A, Tamano S, Ogiso T, Asakawa E, Fukushima S.
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [Abstract] [Full Text] [Related]

  • 13. Limited tumor-initiating activity of phenylethyl isothiocyanate by promotion with sodium L-ascorbate in a rat two-stage urinary bladder carcinogenesis model.
    Takagi H, Shibutani M, Uneyama C, Lee KY, Kato N, Inoue K, Hirose M.
    Cancer Lett; 2005 Mar 10; 219(2):147-53. PubMed ID: 15723713
    [Abstract] [Full Text] [Related]

  • 14. Ethanol-extracted propolis enhances BBN-initiated urinary bladder carcinogenesis via non-mutagenic mechanisms in rats.
    Xie XL, Gi M, Fujioka M, Doi K, Yamano S, Tachibana H, Fang H, Kakehashi A, Wanibuchi H.
    Food Chem Toxicol; 2015 Sep 10; 83():193-200. PubMed ID: 26111810
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor mRNA levels as a biomarker for short-term N-butyl-N-(4-hydroxybutyl) nitrosamine-induced rat bladder carcinogenesis bioassay.
    Wakui S, Mutou T, Takahashi H, Ikegami M, Wanibuchi H, Fukushima S.
    J Appl Toxicol; 2015 Feb 10; 35(2):181-90. PubMed ID: 24888239
    [Abstract] [Full Text] [Related]

  • 16. Promoting effects of various agents in rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kurata Y, Asamoto M, Hagiwara A, Masui T, Fukushima S.
    Cancer Lett; 1986 Aug 10; 32(2):125-35. PubMed ID: 3756839
    [Abstract] [Full Text] [Related]

  • 17. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T, Shirai T, Takahashi S, Mutai M, Fukushima S.
    Carcinogenesis; 1988 Nov 10; 9(11):1981-5. PubMed ID: 3180336
    [Abstract] [Full Text] [Related]

  • 18. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX, Wanibuchi H, Murai T, Kitano M, Yamamoto S, Fukushima S.
    Jpn J Cancer Res; 1999 Jan 10; 90(1):16-22. PubMed ID: 10076560
    [Abstract] [Full Text] [Related]

  • 19. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y, Fukushima S, Hirose M, Masui T, Ito N.
    Jpn J Cancer Res; 1985 Sep 10; 76(9):828-34. PubMed ID: 3932281
    [Abstract] [Full Text] [Related]

  • 20. Assessment of chronic toxicity and carcinogenicity in rats of Wingstay 100, a rubber antioxidant/antiozonant.
    Iatropoulos MJ, Williams GM, Wang CX, Brunnemann KD, Leber AP.
    Exp Toxicol Pathol; 1997 Aug 10; 49(3-4):153-65. PubMed ID: 9314049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.